| Name | Title | Contact Details |
|---|
Omnilux is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hortense and Louis Rubin Dialysis Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Troy, NY. To find more information about Hortense and Louis Rubin Dialysis Center, please visit www.rubindialysis.org
Headquartered in Omaha, Nebraska, Banyan Medical Systems, Inc. is a leading-edge medical software development and integration company dedicated to creating solutions that transform healthcare professionals` ability to access and interact with patient information. Our products and services are also designed to optimize efficiency, improve workflow, help ensure patient safety, and provide the highest levels of productivity and flexibility. As a result, we are uniquely positioned to provide healthcare professionals with the vital information they need to deliver better, more personalized healthcare to patients whether it be in the OR, clinic, or through real-time collaboration. Banyan Medical Systems healthcare services include consultation, software development and installation, training, and service support, as well as innovative custom solutions. Banyan has developed a series of integrated solutions that provide advantages not offered elsewhere, including: •Integration with all platforms, regardless of vendor •Ability to leverage current equipment and software, creating a seamless system •Scalability for easy expansion or re-design •Portability, including remote access
Health Hero Network, Inc. is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Established in 1946, OMRF is an independent, nonprofit biomedical research institute with more than 450 staff and over 50 labs studying cancer, heart disease, autoimmune disorders, and diseases of aging. Breakthroughs in our labs have led to three FDA-approved drugs, including the first targeted therapy approved in the U.S. for sickle cell disease and the first approved treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease. OMRF`s critical research is helping people live longer, healthier lives, one discovery at a time. Along the way, OMRF has garnered worldwide media attention, from leading scientific publications like The New England Journal of Medicine and Science to The New York Times and The Wall Street Journal. By pushing the boundaries of biomedical science, our researchers are helping to win the war against human disease, one discovery at a time.